It remains not fully understood how ADT may directly cause serious cardiovascular events, but there is evidence that ADT has a detrimental metabolic impact, can decrease insulin sensitivity and lead to dyslipidemia.16, 31, 32. This evidence concerns the gene INS and metabolic syndrome.